Rubin Museum lists its Chelsea building to fund a traveling program

The Rubin Museum of Himalayan Art has retained JLL to sell its six-story, 80,000-square-foot Chelsea building at 140–154 West 17th Street as it moves away from operating a single location, Commercial Observer first reported; the mid-19th-century property between Sixth and Seventh avenues is being marketed without a published asking price.

The basis is old enough to be the story on its own: Donald and Shelley Rubin, the museum's founders, bought the building from Barneys for $22 million, opened the Rubin at the address in 2004, and closed it in October 2024, twenty-six years after the purchase. Barneys had run the building as a Manhattan flagship in the 1980s, hiring Beyer Blinder Belle to turn adjoining apartments into the women's department, and the same firm adapted the space for the museum in 2004. Proceeds from a sale are to fund programming built around traveling exhibitions and long-term loans of objects to other museums.

David Carlos, who heads JLL's nonprofit, education and government practice, describes the building as suited to cultural, educational, commercial or mixed-use uses and calls such opportunities rare in today's market, while executive director Jorrit Britschgi cites the brokerage's record with nonprofits and institutions — broker phrasing, but the underwriting follows from it: the winning bid will likely come from whichever buyer can stack the most uses on a mid-19th-century shell, which makes the museum chapter the least valuable of the options. That is consistent with how New York's institutional pricing has run lately — the $302.2 million that ranked the city fourth on CBRE's medical office list was paying for licenses and tenant credit as much as square feet, as this publication reported this month.

The listing withholds the number, which is where this meets the office market's discovery problem: office finds a clearing mechanism only where a trade prints, while undisclosed conversions and vacancy-adjusted comps still carry the market's pricing. In a Chelsea offering with no ask, the comp arrives at the closing table rather than the offering memo.

The Rubin joins the institutions converting a capital asset into an operating budget; it ran a building for two decades and has decided a program travels further, with the $22 million basis underpinning exhibitions and loans. Health systems made the same trade, as we wrote in September, when Northwell's infrastructure outlay reached $170 million once the work stopped being carried as capex.

The building has already been rebuilt twice — apartments into a department store, a department store into a museum — and a third adaptation is the likeliest outcome. The price will be set by what a buyer can do with a 19th-century shell, not by what the Rubin did with it.